A Phase 3 interventional study of Laser and Mechanical debridement in Peri-implantitis, sponsored by University of Michigan. Withdrawn at 1 site in United States. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-04-03.
Sponsored by University of Michigan · Phase 3, Interventional, and Treatment
The primary objective of this study is to compare the clinical outcomes of using Er: YAG laser along with bone graft and barrier membrane to conventional mechanical debridement also with bone graft and barrier membrane in the treatment of peri-implantitis infections.
304 studies on the registry are indexed under Peri-Implantitis; 84 are open to participants now.
Browse Peri-Implantitis studies →University of Michigan is the lead sponsor of 1,475 studies on the registry; 196 are open to participants now.
Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
A laser will be used to clean out the area around the diseased implant to try to regain bone.
Procedure: Laser
Mechanical debridement will be used to clean out the area around the diseased implant to try to regain bone.
Procedure: Mechanical debridement
This is a surgery that the patient will undergo and the laser will be used to clean the surface of the implant.
This is a surgery that the patient will undergo to have the surface of the implant cleaned using hand instruments.
Perio Probing Depth
Time frame: Change in probing depth from beginning of study to 6 months after intervention
Bleeding on Probing
Time frame: Change in bleeding on probing from beginning of study to 6 months after intervention
This study is withdrawn, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Michigan